483
Sciegen Pharmaceuticals IncSciegen Pharmaceuticals Inc – FDA 483, Sep 2, 2022
Record Details
An FDA inspection of Sciegen Pharmaceuticals Inc. in Hauppauge, NY, identified two significant observations. The firm's written procedures for equipment cleaning and maintenance were found to be inadequate, lacking sufficient detail for methods, materials, and sampling locations. Additionally, several pieces of automatic, mechanical, and electronic equipment, including coating machines used for Clopidogrel and Levetiracetam tablets, were not calibrated across their intended operating ranges.
View Company Profile
ID · 500247d4-c1a2-41f6-9bee-15b0e37ef216
Other documents for Sciegen Pharmaceuticals Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.